13 July 2017 - Deborah Wilkes
Archived
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has switched Maloff Protect, Nasonex Allergy Control 0.05% Nasal Spray and Otrivine Extra Dual Relief Nasal Spray Solution to non-prescription status following public consultations.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.